A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis
Publication
, Conference
Mahtani, RL; Crawford, J; Rifkin, R; Dale, D; Brookhart, A; Gawade, PL; Lewis, S; Lawrence, T; Belani, R; Lyman, GH
Published in: CANCER RESEARCH
2021
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2021
Volume
81
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Mahtani, R. L., Crawford, J., Rifkin, R., Dale, D., Brookhart, A., Gawade, P. L., … Lyman, G. H. (2021). A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis. In CANCER RESEARCH (Vol. 81).
Mahtani, Reshma L., Jeffrey Crawford, Robert Rifkin, David Dale, Alan Brookhart, Prasad L. Gawade, Sandra Lewis, Tatiana Lawrence, Rajesh Belani, and Gary H. Lyman. “A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis.” In CANCER RESEARCH, Vol. 81, 2021.
Mahtani RL, Crawford J, Rifkin R, Dale D, Brookhart A, Gawade PL, et al. A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis. In: CANCER RESEARCH. 2021.
Mahtani, Reshma L., et al. “A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis.” CANCER RESEARCH, vol. 81, no. 4, 2021.
Mahtani RL, Crawford J, Rifkin R, Dale D, Brookhart A, Gawade PL, Lewis S, Lawrence T, Belani R, Lyman GH. A multicenter, prospective, observational study to determine the incidence of febrile neutropenia (FN), persistence and G-CSF utilization among cancer patients at high risk for FN receiving pegfilgrastim by an on-body injector (OBI) versus other FN prophylaxis strategies: An interim analysis. CANCER RESEARCH. 2021.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2021
Volume
81
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis